BlackRock
BTTX

BlackRock’s Better Therapeutics, Inc. Common Stock BTTX Stock Holding History

BlackRock’s Portfolio BTTX Stock Details BTTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-88,635
Closed -$17.3K – 5434
2023
Q4 		$17.3K Sell
88,635
-390
-0.4% -$85 ﹤0.01% 5101
2023
Q3 		$32.6K Sell
89,025
-1,365
-2% -$921 ﹤0.01% 5079
2023
Q2 		$97.6K Buy
90,390
+9,223
+11% +$8.92K ﹤0.01% 4923
2023
Q1 		$56.8K Buy
81,167
+798
+1% +$937 ﹤0.01% 5095
2022
Q4 		$88.8K Buy
80,369
+1,645
+2% +$2.43K ﹤0.01% 5080
2022
Q3 		$139K Buy
78,724
+2,776
+4% +$5.06K ﹤0.01% 5079
2022
Q2 		$118K Buy
+75,948
New +$127K ﹤0.01% 5194

Other funds holding BTTX

CIAS
Capital Investment Advisory Services Raleigh, North Carolina $1.37B AUM 20.71% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
APC
Aspire Private Capital Cornelius, North Carolina $443M AUM 14.48% 1-Year Est. Return